Drug recall
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case)) (Lot 13309, Exp.: 01/26), UPC…
FDA recall event 93210 · Class III · ActiPharma, Inc.
Key facts
| Event ID | 93210 |
|---|---|
| Recall numbers | F-0463-2024 |
| Recalling firm | ActiPharma, Inc. |
| Product type | Food |
| Products | ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim. |
| Initiation date | Sep 28, 2023 |
| Report date | Nov 29, 2023 |
| Termination date | Jan 16, 2024 |
| City | Guaynabo |
| State | PR |
| Country | United States |
| FEI number | 3011131543 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: